We are live on
!
Find out more
CCM
Cantillon Capital Management Portfolio holdings
AUM
$665M
1-Year Est. Return
25.91%
This Fund
S&P 500
This Quarter
Est. Return
+3.88%
1 Year Est. Return
+25.91%
3 Year Est. Return
+105.25%
5 Year Est. Return
+112.09%
10 Year Est. Return
+580.93%
AUM
$8.89B
AUM Growth
-$397M
(-4.3%)
Cap. Flow
-$666M
Cap. Flow
% of AUM
-7.49%
Top 10 Holdings %
Top 10 Hldgs %
46.03%
Holding
35
New
1
Increased
3
Reduced
30
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$123M |
| 2 |
Intel
INTC
|
+$83.2M |
| 3 |
Equifax
EFX
|
+$71.4M |
| 4 |
Interactive Brokers
IBKR
|
+$8.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$284M |
| 2 |
Broadcom
AVGO
|
+$109M |
| 3 |
S&P Global
SPGI
|
+$38.2M |
| 4 |
AGN
Allergan plc
AGN
|
+$34.1M |
| 5 |
Analog Devices
ADI
|
+$33.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 29.06% |
| 2 | Technology | 23.49% |
| 3 | Communication Services | 13.47% |
| 4 | Industrials | 11.62% |
| 5 | Healthcare | 11.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
S&P Global
SPGI
$123B
| $562M | 6.33% |
2,878,413
-184,852
| -6% | -$38.2M |
|
|
2
Analog Devices
ADI
$183B
| $479M | 5.39% |
5,183,969
-351,093
| -6% | -$33.7M |
|
3
Fidelity National Information Services
FIS
$21.9B
| $464M | 5.22% |
4,255,326
-284,124
| -6% | -$30.6M |
|
4
Alphabet (Google) Class A
GOOGL
$4.6T
| $425M | 4.78% |
7,041,900
-474,680
| -6% | -$28.7M |
|
5
Visa
V
$687B
| $407M | 4.58% |
2,714,270
-179,282
| -6% | -$25.5M |
|
6
Ecolab
ECL
$78.5B
| $363M | 4.08% |
2,314,322
-157,255
| -6% | -$23.3M |
|
7
Baidu
BIDU
$38.2B
| $351M | 3.95% |
1,535,373
-111,254
| -7% | -$26.1M |
|
8
Intercontinental Exchange
ICE
$83.3B
| $348M | 3.92% |
4,650,277
-313,087
| -6% | -$23.5M |
|
9
Willis Towers Watson
WTW
$31.5B
| $346M | 3.89% |
2,457,179
-161,328
| -6% | -$24.4M |
|
10
Zoetis
ZTS
$31.6B
| $346M | 3.89% |
3,775,991
-247,129
| -6% | -$21.9M |
|
11
CME Group
CME
$94.6B
| $327M | 3.68% |
1,922,762
-127,986
| -6% | -$21.5M |
|
12
American Tower
AMT
$81.1B
| $316M | 3.55% |
2,174,340
-145,112
| -6% | -$21.3M |
|
|
13
Equifax
EFX
$20.6B
| $314M | 3.53% |
2,405,738
+547,986
| +29% | +$71.4M |
|
14
CBRE Group
CBRE
$43.3B
| $312M | 3.5% |
7,065,039
-478,433
| -6% | -$22.8M |
|
15
Becton Dickinson
BDX
$46.8B
| $272M | 3.06% |
1,068,473
-70,630
| -6% | -$17.4M |
|
16
Agilent Technologies
A
$39.1B
| $249M | 2.8% |
3,533,178
-237,601
| -6% | -$15.7M |
|
|
17
Alphabet (Google) Class C
GOOG
$4.57T
| $245M | 2.75% |
4,100,660
-249,240
| -6% | -$14.9M |
|
18
TriNet
TNET
$3.18B
| $238M | 2.68% |
4,232,618
-282,273
| -6% | -$15.9M |
|
19
Sensata Technologies
ST
$6.97B
| $225M | 2.53% |
4,531,051
-301,387
| -6% | -$15.8M |
|
|
20
Broadcom
AVGO
$1.96T
| $224M | 2.52% |
9,080,280
-4,850,310
| -35% | -$109M |
|
21
Aon
AON
$75B
| $201M | 2.27% |
1,310,282
-87,408
| -6% | -$12.8M |
|
|
22
Intel
INTC
$503B
| $197M | 2.21% |
4,158,903
+1,708,761
| +70% | +$83.2M |
|
23
VeriSign
VRSN
$26.9B
| $177M | 1.99% |
1,106,114
-78,191
| -7% | -$12M |
|
24
Meta Platforms (Facebook)
META
$1.49T
| $177M | 1.99% |
1,075,697
-73,010
| -6% | -$13.2M |
|
25
TSMC
TSM
$2.16T
| $175M | 1.97% |
3,962,255
-260,706
| -6% | -$10.8M |
|
Similar funds
MIA
BCP
WSCM
CWP
TAP
IACCIA
AGM
AWA
Cantillon Capital Management's Q3 2018 Portfolio in Review
As of Q3 2018, Cantillon Capital Management held 35 positions worth $8.89B, down 4.3% from $9.29B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Cantillon Capital Management withdrew a net $666M in Q3 2018, closing 1 position and reducing 30 holdings. Its most notable exit was Allergan plc, an estimated $34.1M position sold in full.
By sector, the portfolio is most concentrated in Financials at 29% of assets, up from 29% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Cantillon Capital Management opened a new position in Thermo Fisher Scientific worth $131M.
- Cantillon Capital Management's largest Q3 2018 buy was Thermo Fisher Scientific: 535,849 shares worth $131M.
- Cantillon Capital Management added most to Intel in Q3 2018, an estimated $83.2M increase.
- Cantillon Capital Management's biggest Q3 2018 reduction was Terminix Global Holdings, Inc., cutting an estimated $284M.
- Cantillon Capital Management fully exited Allergan plc in Q3 2018, selling an estimated $34.1M.
- Cantillon Capital Management's ten largest holdings make up 46% of its $8.89B portfolio in Q3 2018.
- Cantillon Capital Management opened 1 new position and closed 1 in Q3 2018.
- Cantillon Capital Management's portfolio value fell 4.3% quarter-over-quarter to $8.89B.
Based on Cantillon Capital Management's 13F filing for Q3 2018, filed 9 Nov 2018.